Vertex mulls over NHS England’s offer for CF drugs

18th July 2018 Uncategorised 0

Vertex Pharmaceuticals is considering a final offer from NHS England on funding for its cystic fibrosis therapies, but said it remains concerned that the deal on the table does not fully reflect the value of its existing and future medicines for the condition.

More: Vertex mulls over NHS England’s offer for CF drugs
Source: News